Crispr, the gene-editing tool, is revolutionizing the speed and scope with which scientists can modify DNA. It is making biology more “programmable than ever before,” writes Wired. Which means that biotech firms are now staking claims in Crispr’s backend systems in a big bet that biology will be the next great computer platform. In that sense, DNA would be the code that runs the platform, while Crispr would be the programming langue.
Brothers Paul and Michael Dabrowski are the founders of Synthego, a company that is using a combination of software engineering and hardware automation to become the Amazon of genome engineering, according to Wired. The brothers are not biologists, instead, they were software engineerings who worked for Elon Musk’s SpaceX. Afterwards, they saw the opportunity to take what they learned building rockets and apply it to gene editing tools. Companies like theirs are part of an industry boom to meet the demand of groups looking to use Crispr—from academic researchers to agtech companies to biopharmaceutical firms.
Thanks for reading InsideHook. Sign up for our daily newsletter and be in the know.
